Wealthspire Advisors, LLC Incyte Corp Transaction History

Wealthspire Advisors, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	BUY	$67.18 - $84.11 $172,988 - $216,583	2,575 New	2,575 $206,000
Q2 2021 Aug 13, 2021	SELL	$79.87 - $87.53 $270,040 - $295,938	-3,381 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$76.02 - $100.5 $257,023 - $339,790	3,381 New	3,381 $275,000
Q1 2019 May 08, 2019	SELL	$63.56 - $88.17 $8,135 - $11,285	-128 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$58.5 - $69.94 $7,488 - $8,952	128 New	128 $8,000

659

186M

714K

557K

Ticker INCY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 222,431,008
Market Cap $16.4B
Description
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally. The company offers JAKAFI, a drug for the treatment of myelofibrosis and polycythemia vera; PEMAZYRE, a fibroblast growth factor receptor kinase inhibitor that act as ...

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthspire Advisors, LLC with notifications on news.